Age | Multiple Myeloma | Patient Appropriate Stem cell transplant
Item
man or woman between age 18-65 with newly diagnosed multiple myeloma for whom stem cell transplantation is considered appropriate
boolean
C0001779 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C1548787 (UMLS CUI [3,2])
C1504389 (UMLS CUI [3,3])
Serum paraprotein measurement | Urine paraprotein measurement
Item
measurable serum and/or urinary paraprotein
boolean
C0585639 (UMLS CUI [1])
C0585640 (UMLS CUI [2])
ECOG performance status
Item
european cooperative oncology group performance status 0-3
boolean
C1520224 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum bilirubin < 1.5x the upper limit of normal (uln)
boolean
C1278039 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
serum alanine transaminase (alt)/aspartate transaminase values < 2.5 x uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Informed Consent | Informed Consent Patient Representatives
Item
subjects (or their legally acceptable representatives) must signed an informed consent document indicating that they understanding the purpose of and procedures required for the study and are willing to participate in the study
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Childbearing Potential
Item
woman of child bearing potential
boolean
C3831118 (UMLS CUI [1])
Non-secretory myeloma
Item
non-secretory mm
boolean
C0456845 (UMLS CUI [1])
Creatinine measurement, serum | Status post Resuscitation Initial
Item
serum creatinine > 400 micromol/l after initial resuscitation
boolean
C0201976 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0035273 (UMLS CUI [2,2])
C0205265 (UMLS CUI [2,3])
Peripheral Neuropathy CTCAE Grades
Item
patients with previous grade 2-4 peripheral neuropathy
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Diabetic - poor control | Antidiabetics Dose Stable
Item
uncontrolled diabetes (if receiving antidiabetic agents, subjects must be on a stable dose for at least 3 months before first dose of study drug
boolean
C0421258 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Angina Pectoris Uncontrolled | Disorder of pericardium | Heart failure NYHA
Item
uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrollment, uncontrolled angina, clinically significant pericardial disease, or iii-iv heart failure
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0002962 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0265122 (UMLS CUI [5])
C0018801 (UMLS CUI [6,1])
C1275491 (UMLS CUI [6,2])